Manuka, Inc. is a biopharmaceutical company. The Company’s products include Face Serum with Manuka Honey and Bee Venom, Face Serum with Enhanced Vitamin C, Day Cream, Nourishing Night Cream with Manuka Honey and Nee Venom, Eye Cream with Manuka Honey and Bee Venom, Face Cleanser Gel and Face Serum. Its Face Serum with Manuka Honey and Bee Venom supports blurring and reduces skin wrinkles. The company regenerates skin cells and gives a young and vital appearance to the skin. The bee venom encourages natural skin revival, boosts production of Collagen, enhances skin elasticity and has healing properties for damages skin cells.
How did MNKA's recent EPS compare to expectations?
The most recent EPS for Manuka Inc is $, expectations of $.
How did Manuka Inc MNKA's revenue perform in the last quarter?
Manuka Inc revenue for the last quarter is $
What is the revenue estimate for Manuka Inc?
According to of Wall street analyst, the revenue estimate of Manuka Inc range from $ to $
What's the earning quality score for Manuka Inc?
Manuka Inc has a earning quality score of B/40.675587. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Manuka Inc report earnings?
Manuka Inc next earnings report is expected in 2025-02-19
What are Manuka Inc's expected earnings?
Manuka Inc expected earnings is $, according to wall-street analysts.